Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer

Por Smith, Matthew R., Klotz, Laurence, Persson, Bo-Eric, Olesen, Tine Kold, Wilde, Arthur A. M.
Publicado em 2010

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential...

Por Ulmert, David, Vickers, Andrew J., Scher, Howard I., Becker, Charlotte, Iversen, Peter, Frankel, David, Jensen, Jens-Kristian, Olesen, Tine Kold, Lilja, Hans
Publicado em 2012